Compare NEPH & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEPH | MLSS |
|---|---|---|
| Founded | 1997 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 42.6M |
| IPO Year | 2004 | 1996 |
| Metric | NEPH | MLSS |
|---|---|---|
| Price | $3.52 | $0.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $6.25 | $1.25 |
| AVG Volume (30 Days) | 34.6K | ★ 80.5K |
| Earning Date | 11-05-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1000.00 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $18,789,000.00 | $8,973,982.00 |
| Revenue This Year | $17.81 | $11.14 |
| Revenue Next Year | $15.90 | $13.80 |
| P/E Ratio | $29.92 | ★ N/A |
| Revenue Growth | ★ 32.67 | 3.99 |
| 52 Week Low | $2.66 | $0.22 |
| 52 Week High | $6.42 | $0.58 |
| Indicator | NEPH | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 28.29 |
| Support Level | $2.86 | $0.30 |
| Resistance Level | $3.78 | $0.40 |
| Average True Range (ATR) | 0.31 | 0.03 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 41.32 | 22.68 |
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.